2025-09-28 - Analysis Report
Okay, here's an analysis of Air Products and Chemicals (APD) based on the data you provided. I'll format it as a concise report.

## Air Products and Chemicals Inc. (APD) Analysis

**Ticker:** APD
**Company Description:** Air Products and Chemicals Inc. supplies industrial gases and related equipment to various industries.

### 1. Performance vs. S&P 500 (VOO)

*   **APD Cumulative Return:** 11.80%
*   **VOO Cumulative Return:** 66.41%
*   **Absolute Divergence:** -54.61%
*   **Divergence Range:** (Max: 18.6, Min: -82.7)
*   **Relative Divergence:** 0.0

**Analysis:** APD has significantly underperformed the S&P 500 over the tracked period. The relative divergence indicates it's currently at the lowest end of its historical performance range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha  | Beta  | Cap(B) |
| :----------- | :------ | :------ | :----- | :---- | :------ |
| 2015-2017  | 17.0%   | 64.6%   | 8.0%  | -0.1  | 36.5   |
| 2016-2018  | 13.0%   | 69.6%   | 14.0% | 0.3   | 35.6   |
| 2017-2019  | 35.0%   | 69.8%   | 31.0% | 0.9   | 52.3   |
| 2018-2020  | 17.0%   | 78.0%   | -9.0% | 0.8   | 60.8   |
| 2019-2021  | 50.0%   | 78.0%   | 21.0% | 0.4   | 67.7   |
| 2020-2022  | 38.0%   | 79.6%   | 24.0% | 0.4   | 68.6   |
| 2021-2023  | -3.0%   | 79.6%   | -21.0% | 0.5   | 60.9   |
| 2022-2024  | -17.0%  | 79.6%   | -29.0% | 0.5   | 64.5   |
| 2023-2025  | -66.0%  | 74.7%   | -101.0% | 1.1   | 59.4   |

**Analysis:** The table shows a declining trend in CAGR and Alpha, especially in recent years (2021-2025).  Beta has generally been low, indicating less volatility relative to the market, but has increased to 1.1 in the latest period.  The negative Alpha values in recent years are concerning. MDD (Maximum Drawdown) is consistently high, suggesting significant potential losses.

### 2. Recent Price Action

*   **Current Price:** 266.78
*   **Previous Close:** 265.78
*   **Change:** 0.38 (Slight upward movement)
*   **5-day Moving Average:** 273.796
*   **20-day Moving Average:** 286.2135
*   **60-day Moving Average:** 290.125

**Analysis:** The price is currently below all three moving averages (5, 20, and 60-day), indicating a potential downtrend.  The slight positive change in the last market day is not enough to reverse this trend.

### 3. Technical Indicators and Risk Assessment

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 29.47 (Oversold)
*   **PPO:** -0.97 (Bearish)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (375 shares - Very Safe - MRI:0.90) (Cash Ratio: 0% on 2025-08-21)
*   **20-day Relative Divergence Change:** -2.1 (Negative - Short-term Decline)
*   **Expected Return:** -3385.2% (Significant Underperformance Expected)

**Analysis:** While the MRI suggests a "High Investment Recommended" based on its model, other indicators paint a more cautious picture. The RSI indicates the stock is oversold, potentially suggesting a possible bounce. The negative PPO confirms the bearish trend. The significant negative Expected Return is a major red flag, indicating a substantial projected underperformance compared to the S&P 500 over a long-term investment horizon.  The Hybrid signal, which is recommending to buy, should be viewed with caution given the other negative indicators.

### 4. Recent News & Analyst Opinions

*   **News:** Recent news is mixed, including articles about the stock being potentially undervalued, comparisons to other value stocks, and analyst upgrades and price target adjustments. The news regarding "Freshline® Food Freezing Solutions" is sector-specific and doesn't strongly impact overall sentiment.
*   **Analyst Consensus:**  The analyst consensus is "~Buy" with an average rating of 1.87. The average target price is $324.14, significantly higher than the current price. Recent rating changes are not provided, so a trend cannot be determined.

### 5. Recent Earnings Analysis

| 날짜         | EPS   | 매출       |
| :----------- | :---- | :--------- |
| 2025-07-31   | 3.2   | 3.02 B$    |
| 2025-05-01   | -7.77 | 2.92 B$    |
| 2025-02-06   | 2.77  | 2.93 B$    |
| 2024-08-01   | 3.13  | 2.99 B$    |
| 2025-07-31   | 3.13  | 2.99 B$    |

**Analysis:** The EPS (Earnings Per Share) shows volatility, with a significant negative value in 2025-05-01. Revenue has been relatively stable around $3 Billion. The inconsistent EPS performance is a concern.

### 6. Financial Information

| Quarter    | Revenue  | Profit Margin |
| :--------- | :------- | :------------ |
| 2025-06-30 | $3.02B  | 32.51%        |
| 2025-03-31 | $2.92B  | 29.57%        |
| 2024-12-31 | $2.93B  | 31.21%        |
| 2024-09-30 | $3.19B  | 33.98%        |
| 2024-06-30 | $2.99B  | 32.82%        |

| Quarter    | Equity    | ROE      |
| :--------- | :-------- | :------- |
| 2025-06-30 | $15.54B  | 4.59%   |
| 2025-03-31 | $14.70B  | -11.77%  |
| 2024-12-31 | $16.69B  | 3.70%   |
| 2024-09-30 | $17.04B  | 11.45%  |
| 2024-06-30 | $15.10B  | 4.61%   |

**Analysis:**  Revenue is generally consistent. Profit margins are healthy, consistently above 30%.  However, ROE (Return on Equity) is highly volatile, with a significant negative value in 2025-03-31. Equity also fluctuates. The ROE volatility aligns with the EPS volatility seen earlier.

### 7. Overall Assessment

Air Products and Chemicals (APD) presents a mixed picture.

*   **Negatives:** Significant underperformance compared to the S&P 500, recent downtrend in price, negative PPO, oversold RSI, volatile EPS and ROE, concerning negative expected return, recent negative Alpha.
*   **Positives:** High Market Risk Indicator (though potentially misleading), "Buy" analyst consensus, consistent revenue and healthy profit margins, oversold RSI might indicate a short term bounce.

**Conclusion:** While analysts generally rate APD as a buy and revenue/profitability is stable, the significant underperformance relative to the S&P 500, the negative trend in recent years in many factors, volatile earnings, and extremely negative expected return raise significant concerns. The analyst consensus may not fully reflect the recent negative performance trends. **A cautious approach is warranted. Further investigation into the reasons for the underperformance, EPS/ROE volatility, and the basis for the extremely negative expected return is strongly recommended before considering an investment.**
